Viewing StudyNCT04666168



Ignite Creation Date: 2024-05-06 @ 3:32 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04666168
Status: RECRUITING
Last Update Posted: 2020-12-14
First Post: 2020-11-11

Brief Title: A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed Refractory Non Hodgkins Lymphoma
Sponsor: Hebei Senlang Biotechnology Inc Ltd
Organization: Hebei Senlang Biotechnology Inc Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-10-22
Start Date Type: ACTUAL
Primary Completion Date: 2023-10-21
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-10-21
Completion Date Type: ESTIMATED
First Submit Date: 2020-11-11
First Submit QC Date: December 7 2020
Study First Post Date: 2020-12-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-07
Last Update Post Date: 2020-12-14
Last Update Post Date Type: ACTUAL